Search

PremiumAKRO

What does the director see there?

A director at AKRO, a company developing drugs for metabolic and rare diseases, made a large stock purchase worth $8.7 million!

By the SpyStocks desk · 1y ago · 1 min read

The rest of this story is for members

The rest is for members

The story continues: the full timeline, the transaction ranges, and the names the forms carry.

Sign in to keep reading Join the channel

Premium comes through the Telegram channel. Already have a code? Sign in to activate it.

Telegram@TheAmericanDream5

Hot stock alerts, straight to Telegram

Real-time buys, sweeps, and trading halts from the desk. Free to join.

Join the channel

Related Stories

Major move in Somnigroup International: CEO buys almost $1.9 million, day after major deal completion

PremiumInsidersSGI7h ago3 min read

InsidersPremiumSGI

Major move in Somnigroup International: CEO buys almost $1.9 million, day after major deal completion

7h ago · 3 min

Will Pfizer do a Moderna for investors?

PremiumInsidersPFE1d ago4 min read

InsidersPremiumPFE

Will Pfizer do a Moderna for investors?

1d ago · 4 min

Intriguing activity in Madison Air

PremiumInsidersMAIR1d ago3 min read

InsidersPremiumMAIR

Intriguing activity in Madison Air

1d ago · 3 min